{"doi":"10.1016/j.amjcard.2018.03.348","title":"Development of Heart Failure After Initiation of Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-Mutant Adenocarcinoma of the Lung","abstract":null,"journal":"The American Journal of Cardiology","year":2018,"id":615291,"datarank":0.26876392038420827,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.0,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1585817,"name":"Begum Yetis Sayin","orcid":null,"position":1,"is_corresponding":false},{"id":1585818,"name":"Hakan Aksoy","orcid":null,"position":2,"is_corresponding":false},{"id":1585819,"name":"Ali Oto","orcid":null,"position":3,"is_corresponding":false},{"id":124160,"name":"Sercan Okutucu","orcid":"0000-0002-2001-929X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Development of Heart Failure After Initiation of Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-Mutant Adenocarcinoma of the Lung","abstract":null,"is_dataset_classified":null,"base_score":1.791759469228055,"endowment":1.791759469228055,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W2804490319","authors":[],"funders":[],"total_grants":0,"fwci":0.3193,"citation_percentile":0.6005187,"influential_citations":0,"citation_trend":[{"year":2018,"count":1},{"year":2020,"count":1},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0002914918307161?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0002914918307161?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.amjcard.2018.03.348","host_type":"journal"}],"fields_of_study":["Lung Cancer Treatments and Mutations","Colorectal Cancer Treatments and Studies","Gastric Cancer Management and Outcomes"],"mesh_terms":[],"keywords":["Osimertinib","Epidermal growth factor receptor","Adenocarcinoma","Epidermal growth factor","Lung","Medicine","Cancer research","Tyrosine kinase","Mutant","Internal medicine","Receptor","Chemistry","Cancer","Erlotinib","Biochemistry","Gene"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-02T19:37:21.888255Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}